Remove Bioavailability Remove Bioequivalency Remove Vaccine
article thumbnail

Gelteq IPO: Supporting Gel Technology for Oral Drug Delivery

XTalks

The stable gel matrix holds multiple ingredients, offering targeted release and enhanced bioavailability while optimizing patient experience. This regulatory strategy leverages bioequivalence studies to expedite approval, positioning Gelteq’s gel as an alternative to traditional oral delivery forms.